Clinical and Investigative Training

Clinical and Investigative Training
Author :
Publisher :
Total Pages : 20
Release :
ISBN-10 : MINN:31951D03604779A
ISBN-13 :
Rating : 4/5 (9A Downloads)

Book Synopsis Clinical and Investigative Training by : National Cancer Institute (U.S.). Division of Cancer Treatment

Download or read book Clinical and Investigative Training written by National Cancer Institute (U.S.). Division of Cancer Treatment and published by . This book was released on 1980 with total page 20 pages. Available in PDF, EPUB and Kindle. Book excerpt:


Clinical and Investigative Training Related Books

Clinical and Investigative Training
Language: en
Pages: 20
Authors: National Cancer Institute (U.S.). Division of Cancer Treatment
Categories: Cancer
Type: BOOK - Published: 1980 - Publisher:

DOWNLOAD EBOOK

Resources for Clinical Investigation
Language: en
Pages: 98
Authors: Institute of Medicine (U.S.). Committee for the Study of Resources for Clinical Investigation
Categories: Clinical indications
Type: BOOK - Published: 1988 - Publisher: National Academies

DOWNLOAD EBOOK

Principles and Practice of Clinical Research
Language: en
Pages: 447
Authors: John I. Gallin
Categories: Science
Type: BOOK - Published: 2011-04-28 - Publisher: Elsevier

DOWNLOAD EBOOK

The second edition of this innovative work again provides a unique perspective on the clinical discovery process by providing input from experts within the NIH
Sponsor & Clinical Investigator Training - Drugs
Language: en
Pages:
Authors: Kalman Dubov
Categories: Medical
Type: BOOK - Published: 2022-01-07 - Publisher: Kalman Dubov

DOWNLOAD EBOOK

These two modules present detailed training on conducting clinical investigations on drugs. The process to gain marketing approval from the US Food & Drug Admin
Sponsor & Clinical Investigator Training - Module A / Biologics
Language: en
Pages:
Authors: Kalman Dubov
Categories: Science
Type: BOOK - Published: 2022-01-09 - Publisher: Kalman Dubov

DOWNLOAD EBOOK

Clinical investigations with biologics are commonly complex, requiring detailed knowledge of the regulatory frameworks for both drugs and biologics since the Fo